share_log

红日药业(300026.SZ)业绩快报:2023年度净利润5.29亿元 同比下降15.22%

Hongri Pharmaceutical (300026.SZ) Performance Report: Net profit of 529 million yuan in 2023 fell 15.22% year on year

Gelonghui Finance ·  Feb 29 05:01

Gelonghui, Feb. 29 | Hongri Pharmaceutical (300026.SZ) announced its 2023 annual results report. In 2023, the company's total revenue was 6.127 billion yuan, down 7.86% from the same period last year; total profit of 629 million yuan, down 12.19% year on year; net profit attributable to shareholders of listed companies was 529 million yuan, down 15.22% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 398 million yuan; basic earnings per share were 0.18 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment